Nahrungsmittelallergien und -unverträglichkeiten

Literaturverzeichnis:

  1. Stein J, Kist M, Raithel M: Erkrankungen durch Nahrungsmittel. Wissenschaftliche Verlagsgesellschaft Stuttgart 2011
  2. Zar S, Kumar D, Benson MJ. Review article: Food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther 2001; 15: 439–449
  3. Osterballe M et al. The prevalence of food hypersensitivity in young adults. Pediatr Allergy Immunol 2009; 20: 686–692
  4. Raithel M, Hahn EG. Allergische Enteropathie. In: Hahn EG, Riemann JF. Klinische Gastroenterologie. Thieme Verlag 1996; 3. Auflage: 960–965
  5. Raithel M, Hahn EG, Baenkler HW. Klinik und Diagnostik von Nahrungsmittelallergien (Gastrointestinal vermittelte Allergien Grad I – IV). English: Gastrointestinal allergies. Dtsch Ärzteblatt Int 2002; 99: A780–786 [Heft 12]
  6. Vivinus-Nebot M, Dainese R, Anty R, Saint-Paul MC, Nano JL, Gonthier N, Marjoux S, Frin-Mathy G, Bernard G, Hébuterne X, Tran A, Theodorou V, Piche T. Combination of allergy factors can worsen diarrheic Irritable Bowel Syndrome: Role of barrier defects and mast cells. Am J Gastroenterol 2012; 107: 75–81
  7. Weidenhiller M et al. Different kinetics of mediator release can be detected during allergic reactions after oral provocation (double-blind placebo-controlled food challenge). Inflamm Res 2002; 51 Suppl 1: 29–30 IF
  8. Winterkamp S et al. Standardised evaluation of urinary excretion of N-tele-methylhistamine in different periods of age in a healthy population. Inflamm Res 2003; 52: S57–S58
  9. Wang J, Sampson HA. Food allergy. J Clin Invest 2011; 121: 827–835
  10. Komericki P et al. Histamine intolerance: lack of reproducibility of single symptoms by oral provocation with histamine: A randomised, double-blind, placebo-controlled crossover study. Wien Klin Wochenschr 2011; 123(1-2):15–20
  11. Campbell AK, Matthews SB, Vassel N, Cox CD, Nassem R, Chaichi J, Holland LB, Grenn J, Wann KT. Bacterial metabolic toxins: A new mechanism for lactose and food intolerance, and irritable bowel syndrome. Toxicology 2010; 278: 268–276
  12. Niggemann B, Erdmann S, Fuchs T, Henzgen M, Jäger L, Kleine-Tebbe J, Lepp U, Raithel M, Reese I, Saloga J, Vieluf I, Vieths S, Zuberbier T. Standardisierung von oralen Provokationstests bei NMA. Leitlinie der Deutschen Gesellschaft für Allergie und klin. Immunologie (DGAKI), ÄDA & GPA. Allergo J 2006; 15: 262–270 und Allergologie 2006; 29(9): 370–380
  13. Weidenhiller M et al. Histaminintoleranz-Syndrom (HIS): Vielfalt der Mechanismen von physiologischer, pathophysiologischer und toxischer Wirkung und deren Unterscheidung.Z Gastroenterologie 2012; 50: 1302–1309
  14. Schwab D et al. Immunoglobulin E and eosinophilic cationic protein in segmental lavage fluid of the small and large bowel identifies patients with food allergy. Am J Gastroenterol 2001; 96: 508–514
  15. Vatn MH et al. Adverse Reaction to Food: Assessment by double-blind placebo-controlled food challenge and clinical, psychosomatic and immunologic analysis. Digestion 1995; 56: 421–428
  16. Lin XP et al. Local allergic reaction in food-hypersensitive adults despite a lack of systemic food-specific IgE. J Allergy Clin Immunol 2002; 109(5): 879–887
  17. Paajanen L et al. Increased g-IFN secretion from duodenal biopsy samples in delayedtype cow’s milk allergy. Pediatr Allergy Immunol 2005; 16: 439–444
  18. Raithel M et al. Colorectal mucosal histamine release by mucosa oxygenation in comparison with other established clinical tests in patients with gastrointestinally mediated allergy (GMA). W J Gastroenterol 2006 Aug 7; 12(29): 4699–4705
  19. Moneret Vautrin DA, Sainte-Laudy J, Kanny G. Ulcerative colitis possibly due to hypersensitivity to wheat and egg. Allergy 2001; 56: 458–459
  20. Pietzak M. Celiac disease, wheat allergy, and gluten sensitivity: When gluten free is not a fad. J Parenter Enteral Nutr 2012; 36: 68S–75S
  21. Born P et al. Carbohydrate malabsorption in clinical routine: a prospective observational study. Hepatogastroenterology 2006; 71: 673–677
  22. Lomer MCE, Parkes GC, Sanderson JD. Review article: lactose intolerance in clinical practice – myths and realities. Aliment Pharmacol 2008; 27: 93–103
  23. Fernandez-Banares F et al. Sugar malabsorption in functional abdominal bloating: A pilot study on the long-term effect of dietary treatment. Clinical Nutrition 2006; 25: 824–831
  24. Keller J et al. Klinisch relevante Atemtests in der gastroenterologischen Diagnostik, Empfehlungen der Deutschen Gesellschaft für Neurogastroenterologie und Motilität sowie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen. Z Gastroenterol 2005; 43: 1071–1090
  25. Posserud I et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. GUT 2007; 56: 802–808
  26. Jarisch R et al. Histaminintoleranz: Histamin und Seekrankheit. Thieme Verlag 2013; 3. Auflage: 1–175
  27. Reese I, Ballmer-Weber B, Beyer K, Erdmann S, Fuchs T, Kleinetebbe J, Klimek L, Lepp U, Henzgen M, Niggemann B, Saloga J, Schäfer C, Werfel T, Zuberbier T, Worm M. Vorgehen bei Verdacht auf Unverträglichkeit gegenüber oral aufgenommenem Histamin. Allergo J 2012; 21 (1): 22–28
  28. Küfner MA, Schwelberger HG, Ulrich P, Hahn EG, Raithel M. Total histamine degradation capacity (THDC) as an important biological marker of histamine metabolism in human colonic mucosa. Inflamm Res 2002; 51: S87–S88
  29. Niec AM, Frankum B, Talley NJ. Are adverse food reactions linked to irritable bowel syndrome? Am J Gastroenterol 1998; 93: 2184–2190
  30. Schäfer D et al. Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics. Eur Respir J 1999 Mar; 13(3): 638–46
  31. Raithel M, Baenkler HW, Naegel A et al. Significance of salicylate intolerance in diseases of the lower gastrointestinal tract. J Physiol Pharmacol 2005 Sep; 56 Suppl 5: 89–102
  32. Ford AC et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009; 169: 651–658.
  33. Wong BS, Camilleri M, Carlson P, McKinzie S, Busciglio I, Bondar O, Dyer RB, Lamsam J, Zinsmeister AR. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol 2012; 10: 1009–1019
  34. Raithel M et al. Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid – based formula induced remission in a patient with steroid – dependent, chronically active ulcerative colitis. Int J Colorectal Dis 2007; 22(7): 833–839
  35. Rajendran N, Kumar D. Role of diet in the management of inflammatory bowel disease. World J Gastroenterol 2010 Mar 28; 16(12): 1442–1448
  36. Sánchez-Fayos Calabuig P, Martín Relloso MJ, Porres Cubero JC. Multifactorial etiology and pathogenic factors in inflammatory bowel disease. Gastroenterol Hepatol. 2009 Nov; 32(9): 633–52
  37. Raithel M. Therapie und Prophylaxe von Nahrungsmittelallergien (Gastrointestinal vermittelte Allergien Grad I–IV). Falk Titisee Kongressband 2012; 1–10
  38. Eigenmann PhA. Mechanisms of food allergy. Pediatr Allergy immunol 2009; 20: 5 – 11
  39. Heymann M, Darmon N, Dupont C, Dugas B, Hirribaren A, Blaton MA, Desjeux JF. Mononuclear cells from infants allergic to cow’s milk secrete tumor necrosis factor alpha, altering intestinal function. Gastroenterology 1994; 106: 1514 – 1523
  40. Bengtsen U, Nilsson-Balknäs U, Hanson LA, Ahlstedt S. Double blind, placebo controlled food reactions do not correlate to IgE allergy in the diagnosis of staple food related gastrointestinal symptoms. Gut 1996; 39: 130 – 135
  41. Andre´ F, Andre´ C, Colin L, Cavagna S. IgE in stool as indicator of food sensitization. Allergy 1995; 50: 328 – 333
  42. Konturek PC, Rienecker H, Hahn EG, Raithel M. Helicobacter pylori as protective factor against food allergy. Med Science Mon 2008; 14(9): CR453 – CR458
  43. Majamaa H, Miettinen A, Laine S, Ilsolauri E. Intestinal inflammation in children with atopic eczema: faecal eosinophilic cationic protein and tumor necrosis factor alpha as non-invasive indicators of food allergy. Clin Exp Allergy 1995; 26: 181 – 187
  44. Kleine-Tebbe J, Ballmer-Weber B, Beyer K, Erdmann S, Fuchs T, Henzgen M, Huttegger I, Jappe U, Jäger L, Lepp U, Niggemann B, Raithel M, Reese I, Saloga J, Szepfalusi Z, Vieths S, Worm M, Zuberbier T, Werfel T. In-vitro-Diagnostik von IgE-vermittelten Nahrungsmittelallergien. Leitlinie der DGAKI, des ÄDA und der GPA, Allergo J 2010 sowie Allergologie 2010 (in press)
  45. Arslan G, Lillestol K, Mulahasanovic A, Florvaag E, Berstad A. Food hypersensitivity reactions visualised by ultrasonography and magnetic resonance imaging in a patient lacking systemic food specific IgE. Digestion 2006; 73: 111 – 115
  46. Lacono G, Ravelli A, Di Prima L, Scalici C, Bolognini St, Chiappa S, Pirrone G, Licastri G, Carroccio A. Colonic lymphoid nodular hyperplasia in children: Relationship to food hypersensitivity. Clin Gastroenterology and Hepatol 2007; 5: 361 – 366
  47. Kokkonen J, Holm K, Kartunnen TJ, Mäki M. Children with untreated food allergy express a relative increment in the density of duodenal gamma/delta T cells. Scand J Gastroenterol 2000; 35: 1137 – 1142
  48. Frieling1 , K. Meis2 , U. W. Kolck2 , J. Homann2 , A. Hülsdonk1 , U. Haars1 , H.-J. Hertfelder3 , J. Oldenburg3 , H. Seidel3 , G. J. Molderings. Evidence for Mast Cell Activation in Patients with Therapy-Resistant Irritable Bowel Syndrome. Z Gastroenterol 2011; 49(2): 191-194
  49. J. Molderings, J. Homann, S. Brettner, M. Raithel, T. Frieling. Systemische Mastzellaktivierungserkrankung: Ein praxisorientierter Leitfaden zu Diagnostik und Therapie. CME Review article, 05/2014, Dtsch Med Wochenschr, Georg Thieme Verlag
  50. Homann, G.J. Molderings. Histaminintoleranz und Mastozytose: Wie erkennen, wie behandeln?. Vortrag am 08.05.2014 am Universitätsklinikum Bonn
  51. Gerhard J. Molderings1*, Britta Haenisch1,2,3,4, Manuela Bogdanow5, Rolf Fimmers5, Markus M. Nöthen. Familial Occurrence of Systemic Mast Cell Activation Disease. PLoS ONE 8(9): e76241. September 30, 2013
  52. Britta Haenisch, Markus M. Nöthen and Gerhard J. Molderings. Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics. Immunology 2012 Blackwell Publishing Ltd, Immunology, 137, 197–205

<< Vorherige Seite


Print Friendly, PDF & Email

VAEM Frontend vers. 0.1

41 database queries in 0,441